Search Results - "Expert opinion on drug safety"

eJournal

Volume available online?

Journal Article

Phone-based safety monitoring of the first year of baclofen treatment for alcohol use disorder: the BACLOPHONE cohort study protocol

by Rolland, Benjamin Auffret, Marine Labreuche, Julien Lapeyre-Mestre, Maryse Dib, Malek Kemkem, Aomar Grit, Isabelle Drelon, Marie Duhamel, Alain Cabe, Nicolas Vabret, François Guillin, Olivier Baguet, Alexandre Masquelier, Céline Dervaux, Alain Deheul, Sylvie Bordet, Régis Carton, Louise Cottencin, Olivier Jardri, Renaud Gautier, Sophie Published in Expert opinion on drug safety (01.02.2017)

“...Background: In France, baclofen is frequently used off-label for alcohol use disorder (AUD). Baclofen has been associated with diverse adverse events (AEs),...”

Journal Article

Clinical consequences of polypharmacy in elderly

by Maher, Robert L Hanlon, Joseph Hajjar, Emily R Published in Expert opinion on drug safety (01.01.2014)

“...Introduction: Polypharmacy, defined as the use of multiple drugs or more than are medically necessary, is a growing concern for older adults. MEDLINE and...”

Journal Article

Expert opinion on drug safety [electronic resource]

Published in Expert opinion on drug safety

Journal Article

Long-term side effects of glucocorticoids

by Oray, Merih Abu Samra, Khawla Ebrahimiadib, Nazanin Meese, Halea Foster, C. Stephen Published in Expert opinion on drug safety (02.04.2016)

“...Introduction: Glucocorticoids represent the standard therapy for reducing inflammation and immune activation in various diseases. However, as with any potent...”

Journal Article

Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis

by Corona, Giovanni Maseroli, Elisa Rastrelli, Giulia Isidori, Andrea M Sforza, Alessandra Mannucci, Edoardo Maggi, Mario Published in Expert opinion on drug safety (01.10.2014)

“...Introduction: Recent reports have significantly halted the enthusiasm regarding androgen-boosting; suggesting that testosterone supplementation (TS) increases...”

Journal Article

Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine

by Zemek, Filip Drtinova, Lucie Nepovimova, Eugenie Sepsova, Vendula Korabecny, Jan Klimes, Jiri Kuca, Kamil Published in Expert opinion on drug safety (01.06.2014)

“...Introduction: Alzheimer's disease (AD) is a world-wide health problem with implications for an increasing number of people and countries. Populations suffering...”

Journal Article

Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis

by Minozzi, Silvia Bonovas, Stefanos Lytras, Theodore Pecoraro, Valentina González-Lorenzo, Marien Bastiampillai, Anan Judina Gabrielli, Eugenia Maria Lonati, Andrea Carlo Moja, Lorenzo Cinquini, Michela Marino, Valentina Matucci, Andrea Milano, Giuseppe Maria Tocci, Giuliano Scarpa, Raffaele Goletti, Delia Cantini, Fabrizio Published in Expert opinion on drug safety (05.12.2016)

“...Introduction: Five anti-tumor necrosis factor (anti-TNF) agents have received regulatory approval for use in rheumatology: adalimumab, golimumab, infliximab,...”

Journal Article

Hydroxychloroquine in systemic lupus erythematosus (SLE)

by Ponticelli, C Moroni, G Published in Expert opinion on drug safety (04.03.2017)

“...Introduction: Hydroxychloroquine (HCQ) is an alkalinizing lysosomatropic drug that accumulates in lysosomes where it inhibits some important functions by...”

Journal Article

An update on the clinical consequences of polypharmacy in older adults: a narrative review

by Wastesson, Jonas W Morin, Lucas Tan, Edwin C.K Johnell, Kristina Published in Expert opinion on drug safety (02.12.2018)

“...Introduction: Polypharmacy, the use of multiple medications by one individual, is increasingly common among older adults. Caring for the growing number of...”

Journal Article

EGFR TKI combination with immunotherapy in non-small cell lung cancer

by Ahn, Myung-Ju Sun, Jong-Mu Lee, Se-Hoon Ahn, Jin Seok Park, Keunchil Published in Expert opinion on drug safety (03.04.2017)

“...Introduction: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) has significantly improved clinical outcomes compared with chemotherapy...”

Journal Article

A review of existing and emerging digital technologies to combat the global trade in fake medicines

by Mackey, Tim K Nayyar, Gaurvika Published in Expert opinion on drug safety (04.05.2017)

“...Introduction: The globalization of the pharmaceutical supply chain has introduced new challenges, chief among them, fighting the international criminal trade...”

Journal Article

A review of the efficacy and safety of oral antidiabetic drugs

by Stein, Stephanie Aleskow Lamos, Elizabeth Mary Davis, Stephen N Published in Expert opinion on drug safety (01.03.2013)

“...Introduction: Additional oral antidiabetic agents to metformin, sulfonylureas (SU) and thiazolidinediones (TZD) are approved for the treatment of type 2...”

Journal Article

Infection risk associated with anti-TNF-α agents: a review

by Murdaca, Giuseppe Spanò, Francesca Contatore, Miriam Guastalla, Andrea Penza, Elena Magnani, Ottavia Puppo, Francesco Published in Expert opinion on drug safety (01.04.2015)

“...Introduction: TNF-α is a pro-inflammatory cytokine known to a have a key role in the pathogenesis of chronic immune-mediated diseases. TNF-α inhibitors can be...”

Journal Article

An update on the safety of SGLT2 inhibitors

by Scheen, André J Published in Expert opinion on drug safety (03.04.2019)

“...Introduction: Sodium-glucose cotransporter type 2 inhibitors (SGLT2is) are recommended after metformin for a large spectrum of patients with type 2 diabetes,...”

Journal Article

Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes

by Scheen, André J Published in Expert opinion on drug safety (01.04.2015)

“...Introduction: Dipeptidyl peptidase-4 (DPP-4) inhibitors (gliptins) occupy a growing place in the armamentarium of drugs used for the management of...”

Journal Article

A systematic review of the safety of probiotics

by Didari, Tina Solki, Sara Mozaffari, Shilan Nikfar, Shekoufeh Abdollahi, Mohammad Published in Expert opinion on drug safety (01.02.2014)

“...Introduction: There is growing evidence on the use of probiotics in various diseases, especially in gastrointestinal (GI) diseases. Although probiotics have...”

Journal Article

Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel

by Banach, Maciej Rizzo, Manfredi Toth, Peter P Farnier, Michel Davidson, Michael H Al-Rasadi, Khalid Aronow, Wilbert S Athyros, Vasilis Djuric, Dragan M Ezhov, Marat V Greenfield, Robert S Hovingh, G Kees Kostner, Karam Serban, Corina Lighezan, Daniel Fras, Zlatko Moriarty, Patrick M Muntner, Paul Goudev, Assen Ceska, Richard Nicholls, Stephen J Broncel, Marlena Nikolic, Dragana Pella, Daniel Puri, Raman Rysz, Jacek Wong, Nathan D Bajnok, Laszlo Jones, Steven R Ray, Kausik K Mikhailidis, Dimitri P Published in Expert opinion on drug safety (01.06.2015)

“...Statins are one of the most commonly prescribed drugs in clinical practice. They are usually well tolerated and effectively prevent cardiovascular events. Most...”

Journal Article

The safety of gliptins : updated data in 2018

by Scheen, André Jacques Published in Expert opinion on drug safety (03.04.2018)

“...Introduction: Dipeptidyl peptidase-4 inhibitors (DPP-4is) are generally considered as glucose-lowering agents with a safe profile in type 2 diabetes. Areas...”

Journal Article

An update of safety of clinically used atypical antipsychotics

by Orsolini, L Tomasetti, C Valchera, A Vecchiotti, R Matarazzo, I Vellante, F Iasevoli, F Buonaguro, E. F Fornaro, M Fiengo, A. L. C Martinotti, G Mazza, M Perna, G Carano, A De Bartolomeis, A Di Giannantonio, M De Berardis, D Published in Expert opinion on drug safety (02.10.2016)

“...Introduction: The atypical antipsychotic (APs) drugs have become the most widely used agents to treat a variety of psychoses because of their superiority with...”

1
2
3
4
5
6
7
8
9
10
11
Next »
[50]

Narrow search